SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending as investors grapple with a significant disconnect between record-breaking quarterly financial performance and a suppressed stock price. The community is actively debating whether the current price action is driven by institutional manipulation, sector-wide consumer softness, or concerns regarding brand cannibalization and competitive pressure from rivals.

Twin Vee PowerCats Co. engages in the design, manufacture, and sale of recreational and commercial power catamaran boats. The firm is focused on designing and developing its products under the ELECTRA Power Sports brand. It operates through the Twin Vee PowerCats and Wizz Banger, Inc. Segments. The Twin Vee PowerCats segment designs, manufactures, and sells recreational and commercial powerboats. The Wizz Banger, Inc. segment refers to a development-stage subsidiary with plans to develop an innovative online marketplace leveraging artificial intelligence (AI) to transform how customers search for and purchase recreational marine assets. The company was founded by Roger Dunshee in 1996 and is headquartered in Fort Pierce, FL.

Twin Vee PowerCats Co

Twin Vee PowerCats is seeing significant retail interest driven by its ultra-low micro-float status and momentum following a reverse stock split. The community is actively discussing the stock's squeeze potential, drawing comparisons to other high-volatility runners and pointing to recent insider buying as a catalyst for a potential parabolic move.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a positive pre-BLA meeting with the FDA, which confirmed a clear regulatory path toward a late-2026 BLA submission with potential priority review. Community discourse is heavily focused on the company's best-in-class label potential, strong cash position through 2027, and anticipation of upcoming Phase 3 trial data readouts.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is experiencing a volatile surge driven by intense retail and institutional momentum, as traders draw parallels to the recent multi-week squeezes in larger memory sector peers. Investors are actively discussing the stock's potential as a low-float, high-upside play within the Edge AI and defense-infrastructure space, with many anticipating further upside despite discussions regarding legal challenges and valuation.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust is capturing significant investor attention as market participants debate whether silver is entering a long-term breakout cycle driven by rising industrial demand and supply chain concerns. Community sentiment is deeply divided, with many traders actively discussing potential short squeezes and hedging strategies while others remain skeptical about the sustainability of current price action amidst broader macroeconomic volatility.

Odysight.ai, Inc. engages in the development and manufacture of customized visual solutions for organizations across a variety of industries in the form of micro cameras and supplementary technologies. Its devices can used across the medical, aerospace, industrial, research, and defense industries. The company was founded on March 22, 2013 and is headquartered in Omer, Israel.

Odysight.ai Inc

Odysight.AI Inc

Odysight.AI is currently capturing significant community attention following a cooperative research agreement with the U.S. Navy for AI-driven visual sensing technology. While bulls are excited by the potential for defense-sector growth and momentum, many traders are actively debating the sustainability of the price action and expressing skepticism regarding corporate dilution and past performance.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors debate the timing of long-awaited Phase 3 data for its leukemia candidate, with the community actively split between concerns over trial delays and optimism regarding potential curative efficacy and institutional positioning. The core discussion centers on the lack of an announced 80th event as a sign of durable patient survival versus frustration over the companys silence and repeated requests for stock-based compensation.

Applied Digital Corporation

Applied Digital is trending as investors capitalize on massive AI infrastructure expansion and institutional interest, with the community actively debating whether to hold through potential volatility or lock in gains. Traders are closely monitoring upcoming sector earnings for potential ripple effects, while long-term shareholders remain focused on the company's substantial contracted lease pipeline.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is facing heightened volatility and selling pressure following a revenue guidance miss, as investors weigh strong earnings beats against broader concerns regarding AI disruption in the enterprise SaaS sector. While many community members view the sharp price drop as a disconnect from the company's growth and cash-rich balance sheet, others remain cautious, debating whether established software platforms can effectively pivot or if they are vulnerable to emerging agentic AI competition.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, United Online (UOL), and Consumer Products. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Lingo segment offers a global cloud or unified communications and managed service provider to Enterprise and Small to Medium Businesses in the United States. The magicJack VoIP segment is a non-interconnected Voice-over-IP (VoIP) cloud-based communications service provider that offers related devices and subscription services within the United States and Canada. The Marcon segment is a mobile virtual network operator that provides mobile phone voice, text, and data services and devices using the Credo Mobile brand. The United Online segment is an Internet access provider that offers dial-up and digital subscriber line services under the NetZero and Juno brands across the United States. The Consumer Products segment generates revenue through sales of laptop and computer accessories. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors monitor a potential turnaround, fueled by ongoing strength in its key equity holdings like Babcock & Wilcox and Applied Digital. The community is actively discussing the stock's significant short interest and the potential for a massive upside re-rating as the company clears debt and navigates upcoming quarterly earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BML Capital Management LLC Sells 858,613 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB

BML Capital Management LLC lowered its holdings in shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) by 67.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owne...

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts

Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assig...

Northland Securities Weighs in on CNTB Q1 Earnings

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Equities research analysts at Northland Securities issued their Q1 2026 earnings per share (EPS) estimates for Connect...

Q1 Earnings Estimate for CNTB Issued By HC Wainwright

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Connect Biopharma in a research note issued on Wednesday, April 8th. HC Wainwright analyst B. Folkes expects that the company will post...

Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the five ratings firms that are currently...

Connect Biopharma (NASDAQ:CNTB) Director Buys $4,002,000.00 in Stock

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) Director James Huang acquired 1,160,000 shares of Connect Biopharma stock in a transaction that occurred on Tuesday...

Connect Biopharma (NASDAQ:CNTB) Director James Huang Acquires 1,160,000 Shares

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) Director James Huang bought 1,160,000 shares of the stock in a transaction on Tuesday, March 31st. The stock was purchased at an average cost of $3.45 per share, with a total value of $4,002,000.00. Following the...

Connect Biopharma (NASDAQ:CNTB) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Connect Biopharma (NASDAQ:CNTB - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.27) earnings per share for the quarter, topping analysts' consensus estimates of...

Connect Biopharma (NASDAQ:CNTB) Receives "Buy" Rating from BTIG Research

BTIG Research restated a "buy" rating and issued a $10.00 price target on shares of Connect Biopharma in a research report on Tuesday...

Connect Biopharma touts rapid IV rademikibart FEV1 gains; Phase 3 atopic dermatitis data impresses

Connect Biopharma (NASDAQ:CNTB) shared new clinical and preclinical updates on rademikibart, its IL-4 receptor alpha monoclonal antibody, highlighting preliminary top-line results from an intravenous...

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.

Current Price	$2.37
Prev Close	$2.36
Open	$2.37
Dividend Yield	0.00%
50-Day Moving Average	$2.73
Beta	0.60
Avg. Volume	359,361.52
PE Ratio	-2.37

52-Week High	$3.82
52-Week Low	$0.70
Market Capitalization	$133.39M
EPS (Annual)	-$0.9968
Price to Book	3.17
Revenue Per Employee	$1,000.00

CNTB
Connect Biopharma Holdings Ltd - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest CNTB News

CNTBConnect Biopharma Holdings Ltd - ADR